Black Hawk Acquisition Corp to merge with Vesicor Therapeutics, Inc. in a $70M deal
Black Hawk Acquisition Corp agreed to merge with Vesicor Therapeutics, Inc., a Health Care company, at a headline value of $70M.
The agreement was announced on Monday 3 August, and we hold no shareholder vote date for it yet.